Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2185257 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2252501 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2291502 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2311374 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2346182 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2354044 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2369605 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2428391 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2441103 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2456106 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2501906 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2540727 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2542786 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2590772 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2600352 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2621424 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2695059 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2736228 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2776501 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2795215 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2822759 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2849072 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2874766 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2939565 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2959485 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2984164 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 2997027 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3000147 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3013293 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3069592 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3124880 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3139307 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3144757 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3148277 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3153961 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3160946 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3191199 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3277261 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3283798 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3285787 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3307730 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3312991 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3320771 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3324225 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3324576 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3325520 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3349096 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3374960 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3390290 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3407322 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3434716 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3449711 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3464333 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3490695 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3505967 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3520993 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3547945 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3559308 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3561656 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3571279 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3588089 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3603748 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3614948 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3615605 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3616753 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3632890 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3659530 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3710016 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3712172 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3762512 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3769025 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3790714 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3822283 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3849252 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3886159 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3887103 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3943014 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 3965713 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4045186 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4114457 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4226037 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4467700 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4508018 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4538736 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4616697 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4621664 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4644696 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4702234 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4784090 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4868632 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4936330 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 4987442 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 5078000 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 5107722 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 5111398 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 5321846 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 5440333 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 5536252 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 5618419 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M-H)- | 6847910 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | 2417 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | 3389 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Exemestane | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Exemestane | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 1380 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 9177 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 56485 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 57840 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 59167 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 67023 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 74423 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 76061 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 77497 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 83467 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 86616 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 87194 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 87834 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 88213 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 93304 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 95147 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 95396 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 95414 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 96128 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 96515 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 96683 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 97154 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 99642 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 100825 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 101551 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 103011 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 103839 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 104375 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 105117 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 105571 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 106384 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 106878 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 107002 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 107230 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 107809 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 111069 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 111235 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 112627 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 112771 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 114624 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 114766 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 114924 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 118388 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 118439 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 118539 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 119341 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 123056 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 123282 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 123721 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 123932 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 124191 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | OLEIC ACID (CAS# 112-80-1); (M+NA)+ | 124929 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Return to search page